Vaccines for hookworm infection

Pediatric Infectious Disease Journal

Volumn 16, Issue 10, 1997, Pages 935-940

  Hotez, Peter J ^a   Ghosh, Kashinath ^a   Hawdon, John ^a   Narasimhan, Sukanya ^a   Jones, Brian ^a   Bethony, Jeff ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ancylos tomiasis; Helminth vaccines; Hookworm infection; Vaccines

Indexed keywords

ANCYLOSTOMA VACCINE; UNCLASSIFIED DRUG; VACCINE;

ACTIVE IMMUNIZATION; ANCYLOSTOMA DUODENALE; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DRUG TARGETING; HOOKWORM INFECTION; IMMUNOGENICITY; LARVAL DEVELOPMENT; MOUSE; NECATOR AMERICANUS; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION;

ANCYLOSTOMATOIDEA; ANIMALS; ANTIGENS, HELMINTH; HELMINTH PROTEINS; HOOKWORM INFECTIONS; HUMANS; INTERFERON TYPE II; LARVA; VACCINATION; VACCINES; VACCINES, SYNTHETIC;

EID: 0030826975     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199710000-00006     Document Type: Conference Paper

References (27)

1. Xu LQ, Yu SH, Jiang ZX, et al. Soil-transmitted helminthiases: nationwide survey in China. Bull WHO 1995;73:507-13.
2. Bundy D, Cooper E. Trichuris and trichuriasis in humans. Adv Parasitol 1989;28:107-73.
3. Hotez PJ. Hookworm disease in children. Pediatr Infect Dis J 1989;8:516-20.
4. Nokes C, Bundy D. Does helminth infection affect mental processing and educational achievement? Parasitol Today 1994;10:4-8.
5. Biddulph J. Mebendazole and albendazole for infants. Pediatr Infect Dis J 1990;9:373.
6. Albonico M, Smith PG, Ercole E, Hall A, Hababu CM, Alawi KS. Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. Trans R Soc Trop Med Hyg. 1995;89:538-41.
7. Ottesen EA. Immune response in hookworm infection. In: Hookworm disease. London: Taylor and Francis, 1990:404-16.
8. Cappello M, Vlasuk GP, Bergum PW, Huang S, Hotez PJ. Ancylostoma caninum anticoagulant peptide: a hookworm derived inhibitor of human coagulation factor Xa. Proc Natl Acad Sci USA 1995;92:6152-6.
9. Cappello M, Hawdon JM, Jones BF, Kennedy WP, Hotez PJ. Ancylostoma caninum anticoagulant peptide: cloning by PCR and expression of soluble, active protein in E. coli. Mol Biochem Parasitol 1996;80:113-7.
10. Moyle M, Foster DL, McGrath DE, et al. A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18*. J Biol Chem 1994;269:1008-15.
11. Hotez PJ, Pritchard DI. Hookworm infection. Sci Am 1995; 272:68-75.
12. McCoy OR. Immunity reactions of the dog against hookworm (Ancylostoma caninum) under conditions of repeated infection. Am J Hyg 1931;14:268-303.
13. Cort WW, Otto GF. Immunity in hookworm diseases. Rev Gastroenterol 1940;7:2-14.
14. Miller TA. Vaccination against the canine hookworm disease. Adv Parasitol 1971;9:153-83.
15. Miller TA. Industrial development and field use of the canine hookworm vaccine. Adv Parasitol 1978;16:333-42.
16. Hotez PJ, Hawdon JM, Cappello M, Jones BF, Ghosh K, Volvovitz F, Shu-Hua X. Molecular approaches to hookworm vaccines. Pediatr Res 1996;40:515-21.
17. Hotez PJ, Hawdon JM, Schad GA. Hookworm larval infectivity, arrest and amphiparatenesis: the Caenorhabditis elegans Daf-c paradigm. Parasitol Today 1993;9:23-6.
18. Hawdon JM, Hotez PJ. Hookworm: developmental biology of the infectious process. Curr Opin Genet Dev 1996;6:6:18-23.
19. Hawdon JM, Jones BF, Hoffman D, Hotez PJ. Cloning and characterization of Ancylostoma-secreted protein: a polypeptide associated with the transition to parasitism by infective hookworm larvae. J Biol Chem 1996;271:6672-8.
20. Kerr KB. Studies on acquired immunity to the dog hookworm Ancylostoma caninum. Am J Hyg 1936;23:381-406.
21. Behnke JM. Laboratory Animal models. In: Hookworm disease. London: Taylor & Francis, 1990;10:5-28.
22. Ghosh K, Hawdon JM, Hotez PJ. Vaccination with alum-precipitated recombinant Ancylostoma-secreted protein 1 protects mice against challenge infections with infective hookworm (Ancylostoma caninum) larvae. J Infect Dis 1996; 174:1380-3.
23. Aitken R, Coulson PS, Wilson RA. Pulmonary leukocyte responses are linked to the acquired immunity of mice vaccinated with irradiated cercariae of Schistosoma mansoni. J Immunol 1988;140:3573-9.
24. Mountford AP, Coulson PS, Pemberton RM, Smythies LE, Wilson RA. The generation of interferon-gamma producing T lymphocytes in the skin draining lymph nodes, and their recruitment to the lungs, is associated with protective immunity to Schistosoma mansoni. Immunology 1992;75:250-6.
25. Wilson BA. T cell derived cytokines in lung-phase immunity to Schistosoma mansoni. Mem Inst Oswaldo Cruz 1992; 87(Suppl IV):105-9.
26. Yole DS, Pemberton R, Reid GDP, Wilson RA. Protective immunity to Schistosoma mansoni induced in the olive baboon Papio anubis by the irradiated cercaria vaccine. Parasitology 1996;112:37-46.
27. Yole DS, Reid GDF, Wilson RA. Protection against Schistosoma mansoni and associated immune responses induced in the vervet monkey Cercopithecus aethiops by the irradiated cercaria vaccine. Am J Trop Med Hyg 1996;54:265-70.